Compare NCLH & ATR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NCLH | ATR |
|---|---|---|
| Founded | 1966 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Plastic Products |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.9B | 7.7B |
| IPO Year | 2011 | 1995 |
| Metric | NCLH | ATR |
|---|---|---|
| Price | $19.39 | $132.42 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 4 |
| Target Price | $24.76 | ★ $170.25 |
| AVG Volume (30 Days) | ★ 13.1M | 387.8K |
| Earning Date | 05-04-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 1.56% |
| EPS Growth | N/A | ★ 6.51 |
| EPS | 0.23 | ★ 1.12 |
| Revenue | ★ $5,396,175,000.00 | $3,777,181,000.00 |
| Revenue This Year | $9.96 | $5.18 |
| Revenue Next Year | $6.60 | $4.98 |
| P/E Ratio | ★ $81.35 | $115.18 |
| Revenue Growth | ★ 10.71 | 5.42 |
| 52 Week Low | $14.53 | $103.23 |
| 52 Week High | $27.18 | $161.98 |
| Indicator | NCLH | ATR |
|---|---|---|
| Relative Strength Index (RSI) | 49.07 | 63.22 |
| Support Level | $18.91 | $121.60 |
| Resistance Level | $20.54 | $132.42 |
| Average True Range (ATR) | 0.68 | 2.85 |
| MACD | -0.12 | 0.02 |
| Stochastic Oscillator | 60.53 | 64.81 |
Norwegian Cruise Line is the world's third-largest publicly traded cruise company by berths (around 75,000). It operates 35 ships across three brands—Norwegian, Oceania, and Regent Seven Seas—offering both freestyle and luxury cruising. The company redeployed its entire fleet as of May 2022. With 16 passenger vessels on order among its brands through 2037, representing 43,000 incremental berths, Norwegian is increasing capacity faster than its peers, expanding its brand globally. Norwegian sails to around 700 global destinations.
Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. Its sales are primarily from Europe (49% of sales) and the United States (28%), with China contributing 5% and other countries contributing 17%. It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.